Ieškoti
Visuomenės sveikata
Lisabonos sutartyje sveikatos politikai suteikiama daugiau reikšmės nustatant, kad „žmonių sveikatos aukšto lygio apsauga užtikrinama nustatant ir įgyvendinant visas Sąjungos politikos ir veiklos kryptis“. Šį tikslą numatoma įgyvendinti teikiant Bendrijos paramą valstybėms narėms ir skatinant bendradarbiavimą. Pagrindinė atsakomybė už sveikatos apsaugą, ypač sveikatos priežiūros sistemas, kaip ir anksčiau, tenka valstybėms narėms. Tačiau ES atlieka svarbų vaidmenį gerinant visuomenės sveikatą, užkertant ...
Vaistai ir medicinos prietaisai
Vaistai ir medicinos prietaisai yra produktai, kuriems taikomos bendrosios rinkos taisyklės, todėl kompetencija išduoti jų rinkodaros leidimus atliekant vertinimą ir vykdant priežiūrą suteikta ES. Siekiant saugoti visuomenės sveikatą, prieš į rinką pateikiant naujus vaistus, skirtus naudoti žmonėms, tam turi būti išduotas leidimas taikant arba centralizuotą Europos vaistų agentūros (EMA) procedūrą, arba tai decentralizuotai turi padaryti nacionalinės agentūros. Medicinos prietaisų atveju reikalaujama ...
Commitments Made at the Hearings of the Commissioners-Designate, Juncker Commission (November 2014 - October 2019)
This compilation of briefings presents the most salient points and essential commitments made by the commissioners-designate during the hearings held in September/October 2014 before the parliamentary committees. These commitments concern the main on-going legislative procedures, the preparation of future legislative proposals as well as the scrutiny of the implementation of existing legislation. They also touch upon the crucial issue of inter-institutional cooperation.
Commitments Made at the Hearing of Vytenis Andriukaitis - Commissioner-Designate
Briefing summarises commitments made at the hearing of Vytenis Andriukaitis Commissioner designate for Health & Food Safety.
Commitments Made at the Hearing of Miguel Arias Cañete - Commissioner-Designate
Briefing summarises commitments made at the hearing Miguel Arias Cañete Commissioner designate for Climate Action & Energy.
Disease Mongering (Pseudo-Disease Promotion)
Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern ...
Workshop Report on 'Health in All Policies (HiAP)' - Brussels, 25 May 2011
For many years the health consequences of new legislation have been taken into account during the policy formulation process in areas such as agriculture, environment, food and others. The inclusion of Health in All Policies is now enshrined in the Lisbon Treaty (Art. 168). The aim of the workshop was to present an update on how the system is actually functioning within the different Commission services. Several DGs representatives, led by DG SANCO, made contributions. The case of The Netherlands ...